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Human healthCurrent chemicals regulation operates almost exclusively on a chemical-by-chemical basis, however there is con-
cern that this approach may not be sufﬁciently protective if two or more chemicals have the same toxic effect.
Humans are indisputably exposed to more than one chemical at a time, for example to the multiple chemicals
found in food, air and drinking water, and in household and consumer products, and in cosmetics. Assessment
of cumulative risk to human health and/or the environment from multiple chemicals and routes can be done
in amixture risk assessment (MRA).Whilst there is a broad consensus on the basic science ofmixture toxicology,
the path to regulatory implementation of MRA within chemical risk assessment is less clear.
In this discussion piece we pose an open question: should the scope of human MRA cross legislative remits or
‘silos’?We deﬁne silos as, for instance, legislation that deﬁnes risk assessment practice for a subset of chemicals,
usually on the basis of substance/product, media or process orientation. Currently any form of legal mandate for
humanMRA in the EU is limited to only a few pieces of legislation.We describe two lines of evidence, illustrated
with selected examples, that are particularly pertinent to this question: 1) evidence that mixture effects have
been shown for chemicals regulated in different silos and 2) evidence that humans are co-exposed to chemicals
from different silos. We substantiate the position that, because there is no reason why chemicals allocated to
speciﬁc regulatory silos would have non-overlapping risk proﬁles, then there is also no reason to expect thatans), olwenn.martin@brunel.ac.uk (O.V. Martin), faust@fb-envico.com (M. Faust), andreas.kortenkamp@brunel.ac.uk
. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Examples of regulatory remits (‘silos’) in European Union
Rem
General chemicals control Auth
Class
Special uses of chemicals Pest
Bioc
Hum
Herb
Vete
Emission control Pollu
Indu
Envi
Quality of environmental media Wat
Drin
Air q
Food law Food
Food
Pest
Food
Feed
Feed
Non-food consumer products Gene
Cosm
Occupational health Wor
758 R.M. Evans et al. / Science of the Total Environment 543 (2016) 757–764MRA limited only to chemicals within one silo can fully capture the risk that may be present to human con-
sumers. Finally, we discuss possible options for implementation ofMRA andwe hope to promptwider discussion
of this issue.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction and background
The current approach to chemical regulation routinely depends on as-
sessment on a chemical-by-chemical basis, however there is concern that
this approachmay not be sufﬁciently protective if two or more chemicals
have the same toxic effect on humans (Boobis et al., 2008; Kortenkamp
et al., 2009). Under EU law, the only notable exception to the chemical-
by-chemical paradigm is the Toxic Equivalency Quotient/Factor (TEQ/
TEF) approach (van den Berg et al., 1998) in which dioxin-like
chemicals, including selected polychlorinated biphenyls, dioxins and
furans, are assessed collectively in regulations concerning maximum
limits in food items (Regulation EC No 1881/2006 on setting maximum
levels for certain contaminants in food). Nonetheless, this approach, as
conceived, is limited to the risk assessment of a particular set of com-
pounds (halogenated aromatic hydrocarbons) with a particular proper-
ty (toxicological similarity to dioxin as manifested by AhR activation).
It is incontrovertible that humans are exposed to more than one
chemical at a time, for example to the multiple chemicals found in food,
in air and drinking water, and in household and consumer products and
cosmetics. The unintentional exposure of humans to multiple chemicals
through multiple routes constitutes the ‘mixture’ situation that is the
focus of our interest in this discussion pieces; and our discussion does
not apply directly to commercial products that contain multiple, deﬁned
ingredients, sometimes called ‘intentional’ mixtures. Although the exis-
tence of a mixture per se does not always indicate a risk to human or en-
vironmental health, experimental evidence of mixture effects with
chemicals combined at low, ineffective levels (Kortenkamp, 2014) high-
lights that this should become the topic of assessments that examine
whether more accurate estimations of risk will be produced by consider-
ing all of the chemicals that are present.
Mixture risk assessment (MRA) is the assessment of the cumula-
tive risk to human health or the environment from multiple chemicals
via multiple routes. Whilst there is a broad consensus on the basic
science of mixture toxicology (Kortenkamp et al., 2009; DG Healthlaw.
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tion of these considerations, as an MRA, in chemical risk assessment is
less clear. In theUnited States, guidelines on theHealth Risk Assessment
of Chemical Mixtures have existed for some time (EPA, 1986; 2000). In
Europe, options were outlined in an opinion of the European Food
Safety Authority (EFSA, 2008) and, currently, proposals for MRA
approaches include a Framework developed by WHO/IPCS for “Risk
assessment of combined exposure to multiple chemicals” (Meek et al.,
2011), a decision tree of the European Commission Scientiﬁc Commit-
tees (DG Health and Consumer Protection, 2011) and an approach
examining the contribution of individual mixture components to the
joint effect, termed maximum cumulative ratio (Price et al., 2014).
The German Federal Institute for Risk Assessment (BfR) have drafted a
concept for how to take account of cumulative aspects in the context
of the regulation of plant protection products and biocides (Stein
et al., 2014).
In this discussion piece we pose an open question: should the scope
of human mixture risk assessment (MRA) cross legislative remits? We
have deﬁned legislative remits, or regulatory ‘silos’, as the scope of sin-
gle pieces of legislation that deﬁne the collection of toxicology or mon-
itoring data for a subset of regulated chemicals, for example pesticides,
biocides, food contaminants, food contact materials, pollutants and
pharmaceuticals (Table 1). In the European Union, silos may be based
on substance- or product-oriented regulations (e.g. pesticides, food con-
taminants, pharmaceuticals), media-oriented (e.g. water, soil etc.) or
process-oriented pieces of legislation (e.g. industrial emissions). Cur-
rently any form of legal mandate for MRA in human health is limited
to only a few pieces of legislation, or silos (e.g. maximum residue limits
for pesticides in food; registration, evaluation and authorisation of
chemicals (Kortenkamp et al., 2009)), and so it is likely that the scope
of an MRA will naturally be set within a silo unless the need for a
wider scope is recognised.
If the aspiration is the protection of human health from risks of all
chemicals by all routes and uses, then two lines of evidence areLegislation Type
Regulation (EC) No 1907/2006 Substance-oriented
Regulation (EC) No 1272/2008 Substance-oriented
Regulation (EC) 1107/2009 Substance-oriented
Regulation (EU) 528/2012 Substance-oriented
Directive 2001/83/EC Substance-oriented
Directive 2004/24/EC Substance-oriented
Direction 2001/82/EC Substance-oriented
Directive 2008/1/EC Process-oriented
Directive 2010/75/EU Process-oriented
Directive 85/337/EEC Process-oriented
Directive 2000/60/EC Media-oriented
Directive 98/83/EC Media-oriented
Directive 2008/50/EC Media-oriented
Directive 89/107/EEC Substance-oriented
Regulation (EC) No 1935/2004 Substance-oriented
Regulation (EC) No 396/2005 Substance-oriented
Regulation (EC) No 1881/2006 Substance-oriented
Regulation (EC) No 1831/2003 Substance-oriented
Directive 2001/79/EC Substance-oriented
Directive 2001/95/EC Substance-oriented
Directive 76/768/EEC Substance-oriented
Directive 89/391/EEC Process-oriented
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have been shown for chemicals regulated in different silos and 2) evi-
dence that humans are co-exposed to chemicals from different silos.
We now describe selected examples to demonstrate the evidence avail-
able, without attempting an exhaustive review.We substantiate the po-
sition that, because there is no reason why chemicals allocated to
speciﬁc regulatory silos would have non-overlapping risk proﬁles,
then there is also no reason to expect that MRA limited only to
chemicals within one silo can fully capture the risk that may be present
to human consumers.
2. Mixture effects have been shown for chemicals regulated in
different silos
When chemicals from two or more silos have been combined in
in vitro or in vivo experiments, mixture effects have indeed been
observed. In this case ‘mixture effects’ are deﬁned as either an effect
that was greater than the most potent single chemical in the mixture,
or an effect that was additive (i.e. conformed to a prediction made
using a mathematical concept of additivity such as dose/concentration
addition) or synergistic (Kortenkamp et al., 2009). For example,
in vitro studies using human cell lines have shown additivity for
the end-point of anti-androgenicity for mixtures of up to 30 compo-
nents including chemicals used as pesticides, antioxidants, UV-ﬁlters,
preservatives and plasticizers, and chemicals that are synthetic musks,
parabens, polycyclic aromatic hydrocarbons, perﬂuorinated com-
pounds and polybrominated diphenyl ethers (Ermler et al., 2011;
Orton et al., 2014). These substances can be assigned to multiple
regulatory domains in general chemicals control, special uses of
chemicals, food law or non-food consumer products (see Table 1). Sim-
ilarly, for the in vitro endpoint of estrogenicity, additivity has been
shown for a mixture of 14 chemicals including endogenous hormones,
pharmaceuticals, ﬂame retardants, polycyclic aromatic hydrocarbons,
phytoestrogens, cosmetic ingredients (parabens, UV ﬁlters) and plasti-
cizers (Evans et al., 2012). The available evidence is not limited to end-
points related to receptor interactions, and extends, for example, to
in vitro genotoxicity. A clear mixture effect was observed for the end-
point of micronuclei induction in Chinese Hamster Ovary (CHO) cells
when ﬁve substances (the antihelminthic pesticide ﬂubendazole
and pharmaceuticals doxorubicin, etoposide, melphalan and mito-
mycin C) were combined at levels in the region of their individual
effect thresholds (Ermler et al., 2014).
In vivo studies have also shown mixture effects for developmen-
tal toxicity endpoints such as nipple retention and reduced ventral
prostate weight in male rats. For example, the EU project CONTAMED
showed mixture effects of 13 chemicals including plasticizers,
pesticides, UV-ﬁlters, cosmetic ingredients and pharmaceuticals
(Christiansen et al., 2012; Isling et al., 2014; Axelstad et al., 2014).
Interestingly, one in vivo study of endpoints relating to male sexual
development observed a mild synergistic mixture effect (a mixture
effect greater than that predicted by the concept of dose addition)
for a mixture of four anti-androgens, including a plasticiser, di(2-
ethylhexyl) phthalate, a pharmaceutical, ﬁnasteride, and two fungi-
cides, vinclozolin and prochloraz (Christiansen et al., 2009). The
chemicals included in these in vivo experiments can be assigned to
multiple regulatory domains, such as general chemicals control,
food law, consumer products and pharmaceuticals (see Table 1).
These examples show that chemicals such as pharmaceuticals,
food contaminants, pesticide residues and cosmetic ingredients are
able to produce mixture effects. The possibility that chemicals from di-
verse regulatory silos can act together to produce mixture effects is
not considered in current chemicals regulation. Even chemicals within
certain silos, such as regulations concerning maximum limits for food
contaminants (Regulation EC No 1881/2006), are evaluated without
considering mixture effects, with the exception of polychlorinated
dioxins, furans and biphenyls.Wehave previously supported the use of common toxic effect as the
basis for grouping chemicals in anMRA, instead of using common struc-
tural features or criteria related to usage or regulation, in proposals for
cumulative assessment of phthalate plasticizers (National Research
Council (NRC), 2008) and pesticides (Kortenkamp et al., 2012). EFSA
have recommended that pesticides that produce common adverse
outcomes on the same target organ/system should be grouped together
for thepurpose of assessing cumulative risk in relation tomaximum res-
idue limit (MRL) setting (EFSA, 2013a). These proposals were devel-
oped in the context of distinct regulatory silos, but the underlying
principles could also be applied across silos.
2.1. Chemicals that evoke the same toxic endpoint are regulated in different
regulatory silos
Groups of chemicals that are known to evoke a particular toxic effect
have been shown to belong to different silos. For example, chemicals
known to be developmental neurotoxicants include industrial chemicals,
persistent organic pollutants (POPs), metals and pesticides (Grandjean
and Landrigan, 2014). Examples of developmental neurotoxicants from
different silos are given in Box 1. Grandjean and Landrigan also identiﬁed
218 chemicals as neurotoxic, of which 27 weremetals or inorganic com-
pounds (some of which are regulated as food contaminants), 41 were
organic solvents, 48 were other organic substances, and 102 were
pesticides (Grandjean and Landrigan, 2014); shown visually in Box 2.
As a further example, Mafﬁni and Neltner have listed over 300
chemicals with the potential to harm the developing brain, including
through effects on the thyroid (Mafﬁni and Neltner, 2015). The
chemicals concerned belong to multiple regulatory silos relating to
food and food quality, such as Pesticides, Food contact materials and
Food additives including ﬂavourings, colourings and preservatives; see
Box 3.
These examples show that common, similar or related toxic effects
can be shown for different chemicals that are regulated in different
silos; and that the combined effects of these chemicals across silos are
not currently considered by regulation.
3. Humans have been shown to be co-exposed to chemicals from
different regulatory silos
Studies that measured multiple chemicals in human tissues have
shown thepresence of chemicals fromseveral silos. For example, a bian-
nual monitoring programme in the United States, the National Health
and Nutrition Examination Study (NHANES), measures around 200
chemicals in blood and urine samples from around 10,000 people. The
measured chemicals include persistent organic pollutants (POPs), such
as polychlorinated biphenyls, dioxins and furans and polybrominated
diphenyl ethers, phthalates, phenols, phytoestrogens, pesticides, vola-
tile organic compounds and heavymetals. Byway of a focused example,
we identiﬁed one individual in whom 92 out of 136 chemicals were
present at levels above the limit of detection (NHANES 2003–2004).
Fig. 1 lists the detected chemicals, their groupings and shows the
individual's exposure level (expressed numerically as a percentile of
the exposure levels measured in the whole cohort) with a colour scale
used to indicate exposures towards the top of the cohort distribution
in red and orange, through exposures in the middle of the distribution
in yellow and light green, to exposures towards the bottomof the distri-
bution in dark green. Fig. 1 reveals that this individual's highest expo-
sure percentiles were not restricted to any one class of chemicals
because red shading is not limited to one group, and that their exposure
level varied within each group of chemicals as shown by most groups
having a range of colours from red through yellow to green— indicating
that this individual was highly exposed to some chemicals of each
group, but not to others.
Human breast milk is both a tissue and an exposure source for
breast-fed infants. Breast milk has been found to contain chemicals
Box 1. Developmental neurotoxicants. Graphic shows four groups of chemicals identiﬁed as developmental neurotoxicants (Grandjean and Landrigan, 2014). Widths of coloured blocks
are in proportion to the number of chemicals. The chemicals shown are subject to different pieces of legislation (Table 1), including pesticide residues (pesticides), REACH (industrial
chemicals) and food contaminants (metals, PCBs). POPs are subject to a global treaty, the Stockholm Convention on Persistent Organic Pollutants, to which the EU are signatories.
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phthalates; and as persistent organic pollutants (POPs), including
polybrominated diphenyl ethers (PBDEs) and polychlorinated biphe-
nyls (PCBs) (Schlumpf et al., 2010). Schlumpf et al. carried out amixture
risk calculation for infants consuming breast milk, using the Hazard
Index (HI) approach (Teuschler and Hertzberg, 1995). The calculated
HI was 66 and indicates that, because this value exceeds 1, the mixture
risk is greater than acceptable at this level of assessment - a value of 1
would indicate a risk similar to that of a single chemical being present
at its Reference Dose (the metric used as the ‘acceptable’ level in the
HI calculation). Our presentation of this analysis in Fig. 2 makes it
clear that the overall risk identiﬁed would not be accurately reﬂected
by considering either the individual chemicals (grey bars) or the indi-
vidual groupings (orange bars) alone. The chemical groupings include
chemicals that are not found in any silo, and those found in different
andmultiple silos, for example: both parabens and phthalates are regu-
lated as cosmetics whilst phthalates are also regulated as food contact
materials; the maximum permitted residues of organochlorine pesti-
cides and PCBs are regulated as pesticides and contaminants respec-
tively. PBDE levels are not currently regulated under food law,
however, the international Stockholm Convention on Persistent Organic
Pollutants, which has been signed by the EU, applies for tetra- and penta-
brominated diphenyl ethers, and REACH applies for PBDEs still in com-
mercial use; in addition, quality criteria for PBDE levels in ﬁsh have
been set under the Water Framework Directive for the purpose of pro-
tection of human health.
It is widely accepted that humans are exposed tomultiple chemicals
through multiple routes, and these selected examples show that multi-
ple, diverse chemicals can indeed be measured in human tissues,
including blood and breast milk. However, despite this, the joint risk
to the human body from the total chemical load is not managed by reg-
ulation, or even routinely monitored.
Exposure assessments are a major part of MRA, and there is a need
for both better modelling to predict exposure, especially combinedBox 2.Neurotoxicants. Graphic shows four groups of chemicals identiﬁed as neurotoxicants (Gra
chemicals. The chemicals shown are subject to multiple pieces of legislation (Table 1), inclu
(pesticides).exposures and correlated exposures; and for wider data collection and
surveillance. Themixture that ‘matters’most is the one at the target tis-
sue, and so neither intake (e.g. dietary exposure) nor biomonitoring
(usually of blood or urine as proxies for the other human tissues) are
sufﬁcient alone. Considering this, it seems that data collection at this
scale and level of complexity may well be impractical and so better
modelling, that is precautionary but not overly risk averse, is likely to
be crucial.
4. Discussion
We have presented two lines of evidence; ﬁrstly, that mixture
effects have been observed and can be expected for chemicals that
are regulated in different ‘silos’ and secondly, that humans are exposed
to chemicals from different silos, and chemicals from different silos can
be detected in human tissues. We contend that efforts to regulate
chemicals with the aim of protecting human health therefore need to
contain an approach that can transcend regulatory silos. The silos that
we have referred to here exist to provide a mandate for regulatory
action, often in response to a clearly identiﬁed need, such as recognition
of a toxic effect in an exposed population, or concern that a high risk is
possible if certain activities occur. It is therefore not surprising that cur-
rent silos each delimit their own purview, and do not ‘act on’ or apply to
variables (such as other chemicals and activities) that are outside of
their domain. Almost none of the current silos were deﬁned with mix-
tures in mind, so it is unsurprising that the status quo does not deal
with mixtures; however, if the scientiﬁc case for MRA, and with a
wide scope, can be made, then a broader consideration of possible
risks from combined exposures should follow. This is particularly rele-
vant to pieces of European Union regulations with some scope for
MRA, such as those on setting maximum residue limits for pesticides
(Regulation (EC) No 396/2005) or contaminants (Regulation (EC) No
1881/2006) in food, or all media-oriented regulations (Table 1), to
name a few examples.ndjeanand Landrigan, 2014).Widths of colouredblocks are inproportion to thenumber of
ding REACH (industrial chemicals), food contaminants (metals) and pesticide residues
Box 3. Chemicals potentially harmful to the developing brain. Graphic shows 312 chemicals identiﬁed being potentially harmful to the developing brain, based on in vivo or in vitro
evidence for effects on the brain or thyroid system, and grouped according to food-related use (Mafﬁni and Neltner, 2015). Widths of coloured blocks are in proportion to the number
of chemicals. The chemicals shown are subject to at least three different pieces of legislation (Table 1), including food contact materials, pesticide residues and food additives.
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been 1) the acceptance of dose or concentration addition as suitable
default models (DG Health and Consumer Protection, 2011) and 2) a
shift towards the use of common effects or toxicological proﬁles as the
inclusion criteria rather than detailed mechanistic considerations. A
concrete example of the latter shift is the proposal to form cumulative
assessment groups (CAGs) of pesticides on the basis of their toxicologi-
cal proﬁle (EFSA, 2013b). Since a reviewof the state of the art inmixture
toxicology (Kortenkamp et al., 2009) there have been recent reviews of
regulatory requirements and guidance (JRC, 2014) and scientiﬁc
methodologies (JRC, 2015) for the assessment of mixtures. EFSA have
recently organised a Colloquium on the harmonisation of human and
ecological risk assessment mixtures (EFSA, 2015). The best foundation
for legislation is a robust science and evidence base. These recent
reviews and reports have provided a solid understanding of the exper-
imental evidence base in mixture toxicology and of the related regula-
tions and methods, and can serve as a basis for truly evidence-based
legislation.
Severalmajor challenges inmixture toxicology includewhether, and
how, to integrate cost-beneﬁt analyses in MRA, for example to assess
mixtures that contain components with beneﬁcial effects as well as un-
desirable ones, and interactions. Interactions, cases in which a mixture
has an effect that is greater (synergistic) or smaller than (antagonistic)
the effects predicted by additive models are not yet handled by the
existing proposals for MRA. The most concerning situation for risk
assessment would be a synergy occurring at low concentrations of the
mixture components, and a review of exactly that scenario concluded
that “…the magnitude of synergy, at low doses, did not exceed the
levels predicted by additive models by more than a factor of 4”
(Boobis et al., 2011).
Given the number of possible mixture assessments that could be
conceived of, it is clear that criteria are needed for prioritising those
assessments that are most needed. Potential criteria include whether
potential exposure is signiﬁcant, frequent or large scale;whether poten-
tial effects are severe; whether mixture components persist in the
human body; whether interactions are suspected; if chemical similarity
is predicted; and if any components are assumed to lack an effect
threshold (DG Health and Consumer Protection, 2011; European Com-
mission (EC), 2012). Other factors such as the percentage of themixture
composed of chemicals with speciﬁc or high concern could be assessed
for their suitability as criteria for setting priorities. Themanufacturers of
components of mixtures identiﬁed as priorities could be asked to pro-
vide toxicity and other data to inform the MRA process.
We now discuss the options that are available for addressing the
identiﬁed need for MRA, and which range from amending existing leg-
islation to the creation of a new piece of over-arching legislation.Considerations include whether an approach is scientiﬁcally sound
and will achieve the protection of human health, and also whether
technical and pragmatic factors will affect the implementation of an
approach.
4.1. Could MRA be adequately incorporated into existing chemicals
assessment paradigms?
There are at least three options that build on existing approaches
and activities. Firstly, certain silos have some scope already for dealing
with mixture effects, but currently no methods are implemented in
practice. Good examples of this are pieces of regulation in food law,
such as Regulation EC No 1881/2006 or Regulation (EC) No 396/2005,
andmedia-oriented regulations such as theWater FrameworkDirective
(2000/60/EC) and others concernedwith drinkingwater quality and air
quality (Table 1).
Secondly, two of the existing silos, regulations EC No 396/2005 and
1881/2006, for pesticide and food contaminant residues, respectively,
operate by setting maximum residue levels (MRLs). Mixture consider-
ations could therefore bridge these two silos if the process of setting
of each MRL was able to include considerations of exposures to all
food contaminants and pesticide residues. A proposal as to how infor-
mation about co-exposure to pesticides can be accounted for when set-
ting MRLs within the plant protection product ‘silo’ has been worked
out by the European Food Safety Authority (EFSA, 2008), and this gener-
ic approach could be extended to include food contaminants and other
food-relevant chemicals. However, this approach would not address
mixture risk arising from other chemical groups covered by non-food
regulations, and would naturally focus on exposure via food rather
than other routes. Consequently, there is no logical reason to expect
this to be entirely protective against the plethora of chemicals in use
in the EU and which could contribute to human exposures. However,
this option should be achievable and would be a pragmatic advance.
Despite not addressing all chemicals and routes, it would include
many that are of concern.
Thirdly, there is the option of an additional mixture assessment
factor (MAF) to be used in connection with single chemical assessment
factors (AF). AF are already commonly used in chemical registration or
authorization processes, for example in the context of REACH (Regula-
tion (EC) No 1907/2006) or the Plant Protection Products Regulation
(Regulation (EC) No 1107/2009). The existing single chemical AFs are
expected to cover issues such as the uncertainty in extrapolating data
from animals to human, or the variability within the human popula-
tions, however they do not yet include mixture effects (Martin et al.,
2013). A speciﬁcmixture assessment factor, or MAF, has been discussed
in order to safeguard against unwanted mixture effects from multi-
Fig. 1. Exposure percentiles for 92 chemicals measured in one individual. The ﬁgure shows the exposure of one individual to 92 chemicals, each exposure expressed as the percentile of all
the exposures recorded in the 2003–2004 NHANES cohort. Colour coding indicates percentiles from 100 (red), through orange, yellow, light green to 0 (dark green), see colour scale in
ﬁgure. The chemical abbreviations and groupings used are those given by NHANES. The chemicals shown are subject to multiple pieces of EU legislation (Table 1), including pesticide
residues (pesticides, insecticides), food contaminants (PCBs, furans, dioxins, metals, perchlorate, acrylamide), REACH (volatile organic compounds), food contact materials (Bisphenol
A), cosmetics (Benzophenone-3).
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Fig. 2.Hazard Index analysis of human breast milk. Graph shows values for the Hazard Quotient (intake divided by Reference Dose) for single chemicals (grey bars), groups of chemicals
(orange bars) or the sum of all quotients, the Hazard Index (HI, red bar). Bars for single chemicals are shown above the bar for the group towhich they belongwhenever this information
was provided in the original publication (Schlumpf et al., 2010). Coloured rectangles at the right of the graph indicate regulatory silos (see Table 1) towhich the chemical groupings belong.
Abbreviations used: POP, Stockholm Convention on Persistent Organic Pollutants; WFD, Water Framework Directive; REACH, registration, evaluation, authorisation and restriction of
chemicals; FCM, food contact material; Pest. Res., pesticide residue; Contam., contaminant.
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knowledge about composition would require the MAF to incorporate a
certain amount of conservatism (Backhaus et al., 2010; 2013). As well
as the special case of a mixture of unidentiﬁed composition, the wider
use of an MAF could be envisaged. The advantages of this approach
are that the use of AFs is well-established, common practice and easily
understood, if not always supported froma strictly scientiﬁc perspective
(Martin et al., 2013). Although introduction of a MAF may be the most
pragmatic way of addressing the need for MRA to be introduced into
chemicals risk assessment, there is a major challenge to this approach
in that deﬁning scientiﬁcally sound criteria for setting the magnitude
of this factor may be extremely difﬁcult. Setting a sufﬁciently protective
MAF requires knowledge of the identity and number of chemicals that
make up relevant exposure scenarios. This information is at best frag-
mentary and most often missing entirely, as is toxicity information
that can be fed into the process of MRA. Whether or not the MAF
could be set sufﬁciently large to provide conservative protection of
human health, without being unacceptably restrictive on chemical
use, is a major question.
4.2. Should legislation be enacted that treats the human body as a single
receiving point of chemicals?
To complement incremental modiﬁcations to existing chemical reg-
ulations, is there a case for a new, single piece of legislation that deals
with the human body as a single receiving point for chemicals? Such
legislation could follow the example of the EUWater Framework Direc-
tive (WFD) and could have ﬂexibility in the approaches that it would
mandate in pursuit of the goal of protection of human health from com-
bined chemicals exposures. One avenue could be to provide a mandate
for human biomonitoring to allow an evidence-based assessment of the
extent and frequency of any mixture risk to human populations. New
legislation could complement the implementation of mixture consider-
ations to existing product- or media-oriented legislation or guidance,
with the aim of scrutinising whether the protection goal has been
attained by these regulations. This endeavour would reﬂect the opera-
tion of the EU General Food Law Regulation, (EC) No 178/2002, which
provides an overarching and coherent framework with general princi-
ples, procedures and requirements for the development of food andfeed legislation. The General Food Law Regulation alsomandates neces-
sary infrastructure, such as an independent agency for scientiﬁc advice
and support (EFSA) and procedures for management of crises and
emergencies. However, any advantages of the new legislation approach
need to beweighed against the complexities and challenges of introduc-
ing any piece of legislation, and the possible lack of appetite for such an
endeavour.
Further considerations include whether enforcement is possible or
practical, the challenges for analytical chemistry and biomonitoring,
and whether such legislation would have implications for personal pri-
vacy. Biomonitoring using untargeted chemical analyses, which are not
limited to chemicals selected by the analyst, may allow the chemicals
that should be included in, or prioritised for, an MRA, to be identiﬁed.
In addition, biomonitoring of effective doses could allow the detection
of scenarios in which a mixture effect is present, even when the effect
would not be predicted from single chemical information, and could
warrant further investigation, for examplewith effect-directed fraction-
ation to identify components that should be targets for regulatory
attention.
4.3. Will MRA be ready for toxicology in the 21st century?
Future developments in toxicology, for example in the drive towards
what is called ‘21st Century Toxicology’ (National Research Council
(NRC), 2007), may provide both an opportunity and a need to ensure
that toxicology in the future is capable of dealing with mixtures and
that mixture toxicology keeps pace with the cutting-edge of computa-
tional and high-throughput toxicology. Major aspirations for the future
direction of toxicology include a scientiﬁc and ethical desire to move
away from animal testing, and an improved predictive capability. Fea-
tures such as high throughput screening will provide experimental
data for manymore mixture components, and moves towards probabi-
listic exposure and toxicity/risk assessment should provide both data
and methods that can be used in the assessment of mixtures resulting
in fewer data gaps, less reliance on bridging concepts and default
assumptions and a better grasp of whether an assessment is actually
over-cautious or under protective.
In conclusion, we feel that a wider discussion on the aspirations for
MRA, and on the best path to implementation of MRA, is necessary to
764 R.M. Evans et al. / Science of the Total Environment 543 (2016) 757–764translate the scientiﬁc consensus on mixture toxicity into practicable
and appropriate regulatory approaches. We hope that this discussion
piece will prompt comment and engage the scientiﬁc and regulatory
communities in a wider, open debate on the implementation of MRA.
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